MED vs SCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 03, 2026

MED

53.9
AI Score
VS
MED Wins

SCI

50.4
AI Score

Investment Advisor Scores

MED

54score
Recommendation
HOLD

SCI

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MED SCI Winner
Forward P/E 12.4844 17.2414 MED
PEG Ratio 0.972 1.4373 MED
Revenue Growth -34.3% 2.1% SCI
Earnings Growth -87.2% -1.0% SCI
Tradestie Score 53.9/100 50.4/100 MED
Profit Margin -5.8% 12.4% SCI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, MED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.